创伤性脑损伤合并肺栓塞患者的治疗性抗凝
该回顾性单中心研究纳入2013年6月至2017年12月间年龄大于16岁、同时存在创伤性颅内出血和肺栓塞的患者,共46例接受抗凝治疗。19例(41.3%)在伤后7天内早期抗凝(中位4.1天,四分位距3.1-6天),27例(58.7%)晚期抗凝(中位14天,四分位距9.7-19.5天)。早期组死亡4例、晚期组0例(21.1% vs 0%,p=0.01),其中2例死于肺栓塞;早期组3例、晚期组2例出现CT示颅内出血增加(17.6% vs 7.4%,p=0.3),均无需干预。作者结论认为颅内出血不应妨碍肺栓塞的抗凝治疗,即使伤后早期。
要点
- 46例创伤性颅内出血合并肺栓塞患者接受治疗性抗凝后,无1例因颅内出血加重需要干预。
- 早期抗凝(伤后≤7天,中位4.1天)19例中死亡4例,晚期抗凝(>7天,中位14天)27例中死亡0例(21.1% vs 0%,p=0.01)。
- 早期组3例、晚期组2例CT示颅内出血增加(17.6% vs 7.4%,p=0.3),均未需干预。
- 2例患者尽管接受抗凝仍死于肺栓塞,提示该病严重性。
- 作者结论:颅内出血不应妨碍肺栓塞的抗凝治疗,即使伤后早期。
适用人群与场景
- 年龄大于16岁、同时存在创伤性颅内出血和肺栓塞的患者,数据来自2013年6月至2017年12月的单中心回顾性研究。
诊断标准与关键阈值
- 早期抗凝定义为伤后7天内或更短时间启动;晚期抗凝定义为伤后7天之后启动。
研究设计与关键结果
- 回顾性单中心研究,50例符合标准,4例未接受任何抗凝被排除,最终46例纳入分析。
- 19例(41.3%)接受早期抗凝(中位4.1天,四分位距3.1-6天),27例(58.7%)接受晚期抗凝(中位14天,四分位距9.7-19.5天)。
- 早期组死亡4例,晚期组死亡0例(21.1% vs 0%,p=0.01);其中2例死于肺栓塞,其余死于多系统器官衰竭或不可逆的基础创伤性脑损伤。
- 早期组3例、晚期组2例出现CT示颅内出血增加(17.6% vs 7.4%,p=0.3),均无需干预。
- 采用多因素logistic回归评估与创伤性脑损伤加重相关的临床和人口学因素,并使用递归分割区分组间风险。
证据类型、等级与局限
- 证据类型:回顾性单中心研究;证据等级:照录原文「Care management, Level IV」。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者结论认为,颅内出血不应妨碍肺栓塞的抗凝治疗,即使伤后早期。
- 作者结论认为,治疗性抗凝与创伤性脑损伤患者更差结局无关,即使早期启动。
- 作者指出,2例患者尽管接受抗凝仍死于肺栓塞,强调该病的严重性。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Patients with traumatic intracranial hemorrhage (ICH) and concomitant pulmonary embolus (PE) have competing care needs and demand a careful balance of anticoagulation (AC) versus potential worsening of their ICH. The goal of this study is to determine the safety of therapeutic AC for PE in patients with ICH.
METHODS: This is a retrospective single-center study of patients older than 16 years with concomitant ICH and PE occurring between June 2013 and December 2017. Early AC was defined as within 7 days of injury or less; late was defined as after 7 days. Primary outcomes included death, interventions for worsening ICH following AC, and pulmonary complications. Multivariate logistic regression was used to evaluate for clinical and demographic factors associated with worsening traumatic brain injury (TBI), and recursive partitioning was used to differentiate risk in groups.
RESULTS: Fifty patients met criteria. Four did not receive any AC and were excluded. Nineteen (41.3%) received AC early (median, 4.1; interquartile range, 3.1-6) and 27 (58.7%) received AC late (median, 14; interquartile range, 9.7-19.5). There were four deaths in the early group, and none in the late cohort (21.1% vs. 0%, p = 0.01). Two deaths were due to PE and the others were from multi-system organ failure or unrecoverable underlying TBI. Three patients in the early group, and two in the late, had increased ICH on computed tomography (17.6% vs. 7.4%, p = 0.3). None required intervention.
CONCLUSION: This retrospective study failed to find instances of clinically significant progression of TBI in 46 patients with computed tomography-proven ICH after undergoing AC for PE. Therapeutic AC is not associated with worse outcomes in patients with TBI, even if initiated early. However, two patients died from PE despite AC, underlining the severity of the disease. Intracranial hemorrhage should not preclude AC treatment for PE, even early after injury.
LEVEL OF EVIDENCE: Care management, Level IV.
参考来源
- Chipman AM, Radowsky J, Vesselinov R, et al. Therapeutic anticoagulation in patients with traumatic brain injuries and pulmonary emboli. J Trauma Acute Care Surg. 2020. PMID: 32467467. doi:10.1097/TA.0000000000002805
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。